Cart
sales@molnova.com
Cevidoplenib dimesylate hydrochloride
CAS No. 269062-93-3
Cevidoplenib dimesylate hydrochloride( Cevidoplenib dimesylate hydrochloride(2043659-93-2 Free base) )
Catalog No. M28906 CAS No. 269062-93-3
Cevidoplenib dimesylate hydrochloride is a spleen tyrosine kinase (Syk) inhibitor showing potential immunomodulating and anti-inflammatory properties.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 223 | Get Quote |
|
| 10MG | 357 | Get Quote |
|
| 25MG | 597 | Get Quote |
|
| 50MG | 851 | Get Quote |
|
| 100MG | 1152 | Get Quote |
|
| 500MG | 2313 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameCevidoplenib dimesylate hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionCevidoplenib dimesylate hydrochloride is a spleen tyrosine kinase (Syk) inhibitor showing potential immunomodulating and anti-inflammatory properties.
-
DescriptionCevidoplenib dimesylate hydrochloride is a spleen tyrosine kinase (Syk) inhibitor showing potential immunomodulating and anti-inflammatory properties.(In Vitro):Cevidoplenib dimesylate hydrochloride(oral) inhibited the activity of SYK and blocked Fc receptor and B-cell receptor (BCR)-mediated signaling in inflammatory cells, including macrophages, mast cells, natural killer cells, B cells, and neutrophils.
-
In Vitro——
-
In Vivo——
-
SynonymsCevidoplenib dimesylate hydrochloride(2043659-93-2 Free base)
-
PathwayAngiogenesis
-
TargetSyk
-
RecptorAdenylyl cyclase (AC)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number269062-93-3
-
Formula Weight1957.9
-
Molecular FormulaC90H132Cl5N27O12
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESNCCCC[C@@H](C(N)=O)NC([C@H](CCCNC(N)=N)NC([C@H](CCCNC(N)=N)NC([C@H](CC1=CNC2=C1C=CC=C2)NC([C@H]3N(C([C@H](CC4=CNC5=C4C=CC=C5)NC([C@H](CC6=CNC7=C6C=CC=C7)NC([C@H]8N(C([C@H](CC9=CNC%10=C9C=CC=C%10)NC([C@H](CCCNC(N)=N)NC([C@H](CC(C)C)NC([C@H]([C@@H](C)CC)N)=
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Ramos-Espiritu L, et al. Discovery of LRE1 as a specific and allosteric inhibitor of soluble adenylyl cyclase. Nat Chem Biol. 2016 Oct;12(10):838-44.
molnova catalog
related products
-
Fostamatinib
Fostamatinib (R788 disodium salt) is a prodrug of the active metabolite R406, which is a potent, ATP-competitive inhibitor of Syk kinase with Ki/IC50 of 30/41 nM.
-
LM22B-10
LM22B-10 is an activator of TrkB/TrkC neurotrophin receptor and can induce TrkB, TrkC, ERK and AKT activation in vitro and in vivo.
-
Cevidoplenib dimesyl...
Cevidoplenib dimesylate is an inhibitor of spleen tyrosine kinase (Syk), possessing anti-inflammatory and immunomodulating properties.
